Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation
- PMID: 17179107
- DOI: 10.1200/JCO.2006.05.6879
Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation
Abstract
Purpose: Reduced-intensity protocols for pediatric Hodgkin's lymphoma are aimed at preserving excellent relapse-free survival while decreasing the incidence of late effects.
Patients and methods: We retrospectively reviewed the outcome of 123 children treated consecutively for Hodgkin's lymphoma at a single institution. Patients with stages I-IIIB disease received three cycles of mechlorethamine, vincristine, procarbazine, and prednisone (MOPP)/ doxorubicin, bleomycin, and vinblastine (ABV) followed by 15 Gy of extended-field irradiation, while those with stage IV disease were treated with six to eight cycles of MOPP/ABV chemotherapy with or without radiotherapy.
Results: At a median follow-up of 8.5 years (range, 1.4 to 15.5 years), the estimated 10-year overall survival and event-free survival are 94% (SE, 2.2%) and 88% (SE, 3.1%) respectively. There have been 12 treatment failures and six disease-related deaths. A very large mediastinal mass ( 50% of the maximal thoracic diameter) was associated with a 10-year event-free survival of 50% (SE, 14%) compared with 91% (SE, 4.0%) for smaller masses (P < .001). Late cardiopulmonary toxicity is largely absent, and the incidence of hypothyroidism is 14%. There have been no cases of secondary leukemia and four secondary solid malignancies observed to date.
Conclusion: MOPP/ABV and low-dose, extended-field radiotherapy is an effective treatment for pediatric Hodgkin's lymphoma. With median follow-up of 8.5 years, late cardiopulmonary effects and secondary malignancies from this treatment regimen are infrequent. Continued longitudinal observations, particularly for breast cancer in female patients and gonadotoxicity, will determine whether the goal of decreasing treatment-related complications while maintaining excellent survival has been achieved.
Similar articles
-
Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.N Engl J Med. 2007 Nov 8;357(19):1916-27. doi: 10.1056/NEJMoa064601. N Engl J Med. 2007. PMID: 17989384 Clinical Trial.
-
Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.J Clin Oncol. 2006 Jul 1;24(19):3128-35. doi: 10.1200/JCO.2005.05.2746. Epub 2006 Jun 5. J Clin Oncol. 2006. PMID: 16754934 Clinical Trial.
-
MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.Clin Cancer Res. 2006 Jan 15;12(2):529-35. doi: 10.1158/1078-0432.CCR-05-1707. Clin Cancer Res. 2006. PMID: 16428496 Clinical Trial.
-
[Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].Sangre (Barc). 1998 Jun;43(3):179-84. Sangre (Barc). 1998. PMID: 9741222 Review. Spanish.
-
Hodgkin's disease in children: correlation of clinical characteristics, staging procedures, and treatment at the University of Minnesota.Am J Pediatr Hematol Oncol. 1990 Summer;12(2):147-54. Am J Pediatr Hematol Oncol. 1990. PMID: 1696073 Review.
Cited by
-
Association of Changes in Cancer Therapy Over 3 Decades With Risk of Subsequent Breast Cancer Among Female Childhood Cancer Survivors: A Report From the Childhood Cancer Survivor Study (CCSS).JAMA Oncol. 2022 Oct 13;8(12):1765-74. doi: 10.1001/jamaoncol.2022.4649. Online ahead of print. JAMA Oncol. 2022. PMID: 36227603 Free PMC article.
-
Survival of pediatric Hodgkin lymphoma patients treated with doxorubicin, bleomycin, vincristine, etoposide, prednisone, and cyclophosphamide (ABVE-PC) versus doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) at a single institution.Pediatr Blood Cancer. 2022 May;69(5):e29601. doi: 10.1002/pbc.29601. Epub 2022 Feb 21. Pediatr Blood Cancer. 2022. PMID: 35187850 Free PMC article.
-
Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies.Cancers (Basel). 2021 May 26;13(11):2607. doi: 10.3390/cancers13112607. Cancers (Basel). 2021. PMID: 34073340 Free PMC article. Review.
-
Effect of dose constraint on the thyroid gland during locoregional intensity-modulated radiotherapy in breast cancer patients.J Appl Clin Med Phys. 2019 Jul;20(7):135-141. doi: 10.1002/acm2.12668. Epub 2019 Jun 24. J Appl Clin Med Phys. 2019. PMID: 31231982 Free PMC article.
-
Clinical Profile and Chemotherapy Response in Children with Hodgkin Lymphoma at a Tertiary Care Centre.J Clin Diagn Res. 2015 Nov;9(11):SC25-30. doi: 10.7860/JCDR/2015/14876.6845. Epub 2015 Nov 1. J Clin Diagn Res. 2015. PMID: 26674594 Free PMC article.
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical